Statin use associates with a lower incidence of acute kidney injury after major elective surgery

Journal of the American Society of Nephrology

Volumn 22, Issue 5, 2011, Pages 939-946

  Molnar, Amber O ^a   Coca, Steven G ^b   Devereaux, Phillip J ^c   Jain, Arsh K ^a   Kitchlu, Abhijat ^a   Luo, Jin ^d   Parikh, Chirag R ^b   Michael Paterson, J ^c,d,e   Siddiqui, Nausheen ^a   Wald, Ron ^f   Walsh, Michael ^c   Garg, Amit X ^a,c,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; COHORT ANALYSIS; DIALYSIS; DRUG POTENCY; ELECTIVE SURGERY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR ELECTIVE SURGERY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

EID: 79955591911     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050442     Document Type: Article

References (61)

1. Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 73: 538-546, 2008 (Pubitemid 351264114)
2. O'Donnell D, Clarke G, Hurst P: Acute renal failure following surgery for abdominal aortic aneurysm. Aust N Z J Surg 59: 405-408, 1989 (Pubitemid 19122348)
3. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128: 194-203, 1998 (Pubitemid 28078200)
4. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 53: 961-973, 2009
5. Coca SG, Peixoto AJ, Garg AX, Krumholz HM, Parikh CR: The prognostic importance of a small acute decrement in kidney function in hospitalized patients: A systematic review and meta-analysis. Am J Kidney Dis 50: 712-720, 2007 (Pubitemid 47588552)
6. Braams R, Vossen V, Lisman BA, Eikelboom BC: Outcome in patients requiring renal replacement therapy after surgery for ruptured and non-ruptured aneurysm of the abdominal aorta. Eur J Vasc Endovasc Surg 18: 323-327, 1999 (Pubitemid 29481455)
7. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520, 2006
8. Sharyo S, Yokota-Ikeda N, Mori M, Kumagai K, Uchida K, Ito K, Burne-Taney MJ, Rabb H, Ikeda M: Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int 74: 577-584, 2008
9. Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, Thiemermann C: Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312: 1170-1178, 2005 (Pubitemid 40293778)
10. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13: 2288-2298, 2002 (Pubitemid 34925239)
11. Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D, Luft FC, Haller H: Statins attenuate ischemiareperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 170: 1192-1199, 2007 (Pubitemid 47339327)
12. Sabbatini M, Pisani A, Uccello F, Serio V, Seru R, Paterno R, Cianciaruso B, Fuiano G, Andreucci M: Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 15: 901-909, 2004 (Pubitemid 38375309)
13. Joyce M, Kelly C, Winter D, Chen G, Leahy A, Bouchier-Hayes D: Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemiareperfusion. J Surg Res 101: 79-84, 2001 (Pubitemid 33030111)
14. Kostapanos MS, Liberopoulos EN, Elisaf MS: Statin pleiotropy against renal injury. J Cardiometab Syndr 4: E4-E9, 2009
15. Welten GM, Chonchol M, Schouten O, Hoeks S, Bax JJ, van Domburg RT, van Sambeek M, Poldermans D: Statin use is associated with early recovery of kidney injury after vascular surgery and improved longterm outcome. Nephrol Dial Transplant 23: 3867-3873, 2008
16. Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD: Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol 100: 442-444, 2007 (Pubitemid 47094706)
17. Schouten O, Kok NF, Boersma E, Bax JJ, Feringa HH, Vidakovic R, Statius van Eps RG, van Sambeek MR, Poldermans D: Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol 97: 1383-1385, 2006
18. Kor DJ, Brown MJ, Iscimen R, Brown DR, Whalen FX, Roy TK, Keegan MT: Perioperative statin therapy and renal outcomes after major vascular surgery: A propensity-based analysis. J Cardiothorac Vasc Anesth 22: 210-216, 2008 (Pubitemid 351423689)
19. Huffmyer JL, Mauermann WJ, Thiele RH, Ma JZ, Nemergut EC: Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23: 468-473, 2009
20. Argalious M, Xu M, Sun Z, Smedira N, Koch CG: Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 111: 324-330
21. Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM: Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther 28: 80-86. 2010
22. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D: Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 361: 980-989, 2009
23. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, Caramelli B: Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg 39: 967-975, 2004
24. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC: Effect of different antilipidemic agents and diets on mortality: A systematic review. Arch Intern Med 165: 725-730, 2005 (Pubitemid 40569423)
25. Anonymous: Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288: 2998-3007, 2002
26. Anonymous: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994
27. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, Thomson IR, Lansberg PJ, Fleisher LA, Klein J, van Urk H, Roelandt JR, Boersma E: Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107: 1848-1851, 2003
28. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD: Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110: II45-II49, 2004
29. Noordzij PG, Poldermans D, Schouten O, Schreiner F, Feringa HH, Dunkelgrun M, Kertai MD, Boersma E: Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis 18: 67-72, 2007 (Pubitemid 44973759)
30. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM: Lipidlowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291: 2092-2099, 2004 (Pubitemid 38580152)
31. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T: Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients. Eur Heart J 29: 1548-1559, 2008 (Pubitemid 351881985)
32. Kertai MD, Boersma E, Westerhout CM, Klein J, Van Urk H, Bax JJ, Roelandt JR, Poldermans D: A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28: 343-352, 2004 (Pubitemid 39207082)
33. Josephs S, Thakar C: Perioperative risk assessment, prevention, and treatment of acute kidney injury. Int Anesthesiol Clin 47: 89-105, 2009
34. Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varney J, Johnson J: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333: 15-18, 2006 (Pubitemid 44406838)
35. Platt AB, Kuna ST, Field SH, Chen Z, Gupta R, Roche DF, Christie JD, Asch DA: Adherence to sleep apnea therapy and use of lipidlowering drugs: A study of the healthy-user effect. Chest 137: 102-108
36. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH: Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect. Am J Epidemiol 166: 348-354, 2007 (Pubitemid 47216808)
37. Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL: Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 17: 1688-1694, 2006 (Pubitemid 43794671)
38. Williams J, Young W: A summary of studies on the quality of health care administrative databases in Canada. In: Patterns of Health Care in Ontario. The ICES Practice Atlas, edited by Goel V, Williams JI, Anderson GM, Blackstien-Hirsch P, Fooks C, Naylor CD, Ottawa, Canada, Canadian Medical Association, 1996, pp 339-345
39. Quan H, Parsons GA, Ghali WA: Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care 42: 801-809, 2004
40. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D: Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 10: 67-71, 2003 (Pubitemid 37028596)
41. Jha P, Deboer D, Sykora K, Naylor CD: Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population- based comparison. J Am Coll Cardiol 27: 1335-1342, 1996 (Pubitemid 26153277)
42. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA: An estimation of the global volume of surgery: A modelling strategy based on available data. Lancet 372: 139-144, 2008
43. Vanderbilt University: Short-term Atorvastatin's effect on acute kidney injury following cardiac surgery. In: ClinicalTrials.gov. Bethesda, MD, National Library of Medicine, 2010. Available at http://clinicaltrials. gov/ct2/show/NCT00791648?term=AKI+and+statins&rank=1. NCT00791648
44. Austin Health: The effect of Atorvastatin on postoperative renal func- tion after cardiac surgery. In: ClinicalTrials.gov. Bethesda, MD, National Library of Medicine, 2010. Available at: http://clinicaltrials.gov/ ct2/show/NCT00910221?term=statins+and+AKI&rank=2. NCT00910221
45. Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D: Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: Arandomized controlled trial (DECREASE-IV). Ann Surg 249: 921-926, 2009
46. Statistics Canada: Statistics Canada Census Report in 2006. Available at http://www12.statcan.ca/census-recensement/2006/dp-pd/ prof/92-591/details/Page. cfm?Lang=E&Geo1=PR&Code1= 35&Geo2=PR&Code2=01&Data= Count&SearchText=Ontario& SearchType=Begins&SearchPR=01&B1= All&GeoLevel=&Geo Code=35. 7-24-2009. Accessed November 29, 2009
47. Von EE, Altman DG, Egger M, Popcock SJ, Gotzsche PC, Vandenbroucke JP: The strengthening of the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 61: 344-349, 2008 (Pubitemid 351289042)
48. Tu K, Mamdani MM, Jacka RM, Forde NJ, Rothwell DM, Tu JV: The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. Cmaj 168: 553-557, 2003 (Pubitemid 36324091)
49. Mamdani M, Tu J: Did the major clinical trials of statins affect prescribing behaviour? CMAJ 164: 1695-1696, 2001 (Pubitemid 32702088)
50. Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel TA: Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study. Lancet 363: 1751-1756, 2004 (Pubitemid 38698377)
51. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543-551, 2004 (Pubitemid 39025171)
52. Juurlink D, Mamdani M, Kopp A, Laupacis A, Redelmeier D: Drugdrug interactions among elderly patients hospitalized for drug toxicity. JAMA 289: 1652-1658, 2003 (Pubitemid 37430270)
53. Austin PC, Mamdani MM, Tu K, Jaakkimainen L: Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study. JAMA 289: 3241-3242, 2003 (Pubitemid 37430074)
54. Alter D, Naylor C, Austin P, Tu J: Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341: 1359-1367, 1999 (Pubitemid 29503576)
55. So L, Evans D, Quan H: ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 6: 161, 2006
56. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM: Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330: 960-962, 2005 (Pubitemid 40592320)
57. Austin PC: Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simulation Comput 38: 1228-1234, 2009
58. McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular S: Canadian Cardiovascular Society position statement: Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22: 913-927, 2006 (Pubitemid 44596492)
59. Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD: Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 107: 892-902, 2007 (Pubitemid 350175671)
60. Ouattara A, Benhaoua H, Le Manach Y, Mabrouk-Zerguini N, Itani O, Osman A, Landi M, Riou B, Coriat P: Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23: 633-638, 2009
61. Law MR, Wald NJ, Rudnicka AR: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 326: 1423, 2003